Clipping of news on Brazilian Culture, Law and Citizenship
08/19/2013
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
At high doses, finasteride is indicated for tumor or gland enlargement.
Search denies drug deaths increase aggressive type of the disease.
At high doses, finasteride is indicated to treat prostate cancer and increase (Photo: Charles Dharapak / AP)
A study done by the University of Missouri, USA, on the safety of the drug finasteride suggests that the drug can reduce by 30% the risk of prostate cancer - gland of male reproductive system, the size of a chestnut, which produces part of the semen . The results also suggest that the drug does not increase the deaths from an aggressive form of the disease, and previous studies have concluded.
According to the authors, led by Michael LeFevre, this work may lead to a new perspective on the use of the drug for the prevention of prostate cancer. In the opinion of experts, finasteride could prevent thousands of cases per year in addition to saving many men from treatments with unpleasant side effects.
At high doses, the drug is indicated for treating enlarged prostate (called benign prostatic hyperplasia, which leads to urinary problems) or cancer. Already, at low doses is recommended for baldness.
18 years ago, scientists had found that finasteride could reduce the risk of prostate cancer, but also had been detected a small increase in aggressive tumors among users. According to some researchers, however, the drug did not cause these cancers, only made them stay easier to be detected in a biopsy.
Nevertheless, this concern led the agency Food and Drug Administration (FDA), which regulates foods and drugs in the U.S., to reject finasteride for prevention of prostate cancer, including warnings on product packaging.
To LeFevre, the new study is "reassuring" because if the drug actually stimulated tumors lethal, there would have been more deaths among users over time, which did not occur.
Source: G1 - News
Our news are taken in full from our partner sites. For this reason, we can not change the contents of the same even in cases of typos.
This article was translated by an automatic translation system, and was therefore not reviewed by people.